Selinisol for the treatment of myelofibrosis

Currently, the main clinical application of Selinexor (Selinexor) is for multiple myeloma (Multiple Myeloma, MM). However, for the treatment of myelofibrosis (Bone Marrow Fibrosis), its efficacy is still in the research stage and has not been widely established. However, some of the possible impacts of Seleniso in this area can be explored.

Myelofibrosis is a pathological condition characterized by the proliferation and deposition of fibrous tissue in bone marrow tissue, often associated with bone marrow inflammation, tumors, or other bone marrow diseases. Selinisol, as a nuclear protein transport inhibitor, may have some impact on myelofibrosis in the treatment of multiple myeloma.

The possible therapeutic effects are mainly reflected in the following aspects:

1.Inhibiting the inflammatory process: Selinesol may help reduce the inflammatory response in the bone marrow by affecting the transport of nuclear proteins and interfering with protein transport between the nucleus and the cytoplasm, thereby slowing down the progression of myelofibrosis.

2.Influence on cell cycle: The mechanism of action of selinesol may affect the regulation of cell cycle in bone marrow, which is expected to reduce the excessive proliferation of abnormal cells, thus helping to improve the structure of bone marrow.

3.Reducing symptoms: While treating multiple myeloma, selinesol may reduce symptoms associated with myelofibrosis, such as anemia, fatigue, and bone pain.

Seleniso is already on the market in China and has been included in medical insurance, but its price is quite expensive, about 10,000 to 20,000 yuan, making patients bear higher treatment costs. It is recommended to consult the local hospital pharmacy for specific prices and medical insurance reimbursement status. Different from the domestic market, Seleniso has two options: original drug and generic drug in the foreign market. The original drug is the American version of the original drug. Because of its higher research and development costs, the price is even more expensive, even as high as hundreds of thousands of yuan. In comparison, generic drugs are more affordable. Lao generic drugs are one of the relatively low-priced generic drugs, with prices ranging from 2,000 yuan to 4,000 yuan. Compared with original drugs, they are more affordable. The ingredients of original drugs and generic drugs are basically the same.